Vaccine

Article	Citations
Evidence for antibody as a protective correlate for COVID-19 vaccines	771
Predictors of intention to vaccinate against COVID-19: Results of a nationwide survey	489
Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England	403
Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong	378
International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples	364
mRNA vaccines manufacturing: Challenges and bottlenecks	270
Caregiver willingness to vaccinate their children against COVID-19: Cross sectional survey	265
Myocarditis following COVID-19 mRNA vaccination	210
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge	188
A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine	184
Multisystem inflammatory syndrome in children and adults (MIS-C/A): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	176
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia	165
The public’s role in COVID-19 vaccination: Human-centered recommendations to enhance pandemic vaccine awareness, access, and acceptance in the United States	156
The disease burden of influenza beyond respiratory illness	156
Vaccine hesitancy and anti-vaccination in the time of COVID-19: A Google Trends analysis	146
Epidemiology of COVID-19 infection in young children under five years: A systematic review and meta-analysis	145
Individual preferences for COVID-19 vaccination in China	145
COVID-19 vaccine intentions in the United States, a social-ecological framework	139
Social norms and vaccine uptake: College students’ COVID vaccination intentions, attitudes, and estimated peer norms and comparisons with influenza vaccine	134
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial	130
Towards a population-based threshold of protection for COVID-19 vaccines	130
Vaccination willingness, vaccine hesitancy, and estimated coverage at the first round of COVID-19 vaccination in China: A national cross-sectional study	128
Protective effect of COVID-19 vaccination against long COVID syndrome: A systematic review and meta-analysis	122
Myopericarditis after vaccination, Vaccine Adverse Event Reporting System (VAERS), 1990–2018	121
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)	120

Enablers and barriers to COVID-19 vaccine uptake: An international study of perceptions and intentions	119
Prenatal maternal COVID-19 vaccination and pregnancy outcomes	116
Evaluation of post-introduction COVID-19 vaccine effectiveness: Summary of interim guidance of the World Health Organization	113
The demand for a COVID-19 vaccine in Ecuador	109
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults	109
The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: Use of cost-effectiveness modeling to inform vaccination prioritization	109
Perspectives on the receipt of a COVID-19 vaccine: A survey of employees in two large hospitals in Philadelphia	107
A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis	104
Pregnant women & vaccines against emerging epidemic threats: Ethics guidance for preparedness, research, and response	104
Timing of COVID-19 vaccine approval and endorsement by public figures	102
Preferences for a COVID-19 vaccine in Australia	100
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches	97
Antibody response after first and second-dose of ChAdOx1-nCOV (CovishieldTM®) and BBV-152 (CovaxinTM®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-indu	94
An inventory-location optimization model for equitable influenza vaccine distribution in developing countries during the COVID-19 pandemic	90
Christian nationalism and COVID-19 vaccine hesitancy and uptake	89
Modelling of COVID-19 vaccination strategies and herd immunity, in scenarios of limited and full vaccine supply in NSW, Australia	88
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	85
Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis	84
COVID-19 vaccine – Long term immune decline and breakthrough infections	82
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models	82
Public attitudes toward COVID-19 vaccines on English-language Twitter: A sentiment analysis	81
Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: A model based analysis	76
Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use	76
Understanding immunosenescence and its impact on vaccination of older adults	75
Predicting COVID-19 vaccination intention using protection motivation theory and conspiracy beliefs	74
Assessing vaccine effectiveness against severe COVID-19 disease caused by omicron variant. Report from a meeting of the World Health Organization	73
Older adults' vaccine hesitancy: Psychosocial factors associated with influenza, pneumococcal, and shingles vaccine uptake	73
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	72
The need for inclusion of pregnant women in COVID-19 vaccine trials	71
Efficacy and effectiveness of high-dose influenza vaccine in older adults by circulating strain and antigenic match: An updated systematic review and meta-analysis	71
Global production capacity of seasonal and pandemic influenza vaccines in 2019	70
Older adolescents and young adults willingness to receive the COVID-19 vaccine: Implications for informing public health strategies	70
When politics collides with public health: COVID-19 vaccine country of origin and vaccination acceptance in Brazil	69
Canadian parents’ perceptions of COVID-19 vaccination and intention to vaccinate their children: Results from a cross-sectional national survey	69
Zero-dose children and the immunisation cascade: Understanding immunisation pathways in low and middle-income countries	68
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates	67
Social inequalities in COVID-19 vaccine acceptance and uptake for children and adolescents in Montreal, Canada	67
Prevalence and determinants of SARS-CoV-2 vaccine hesitancy in Hong Kong: A population-based survey	66
Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement	66
Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research	65
Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy	64
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access	64
U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines	63
Parental plans to vaccinate children for COVID-19 in New York city	62
Overcoming COVID-19 vaccine hesitancy among ethnic minorities: A systematic review of UK studies	62
Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK	62
The determinants of vaccine hesitancy in China: A cross-sectional study following the Changchun Changsheng vaccine incident	62
Low COVID-19 vaccine hesitancy in Brazil	61
Conspiracy theories and misinformation about COVID-19 in Nigeria: Implications for vaccine demand generation communications	59
Factors influencing Covid-19 vaccine acceptance across subgroups in the United States: Evidence from a conjoint experiment	59

Myocarditis and pericarditis: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data	59
COVID-19 vaccination rates vary by community vulnerability: A county-level analysis	59
Optimal planning of the COVID-19 vaccine supply chain	58
Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries	56
Neutralization escape by SARS-CoV-2 Omicron subvariant BA.2.86	55
Vaccines based on replication incompetent Ad26 viral vectors: Standardized template with key considerations for a risk/benefit assessment	55
Importance of COVID-19 vaccine efficacy in older age groups	55
Persuasive messaging to increase COVID-19 vaccine uptake intentions	54
The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety	54
Missed childhood immunizations during the COVID-19 pandemic in Brazil: Analyses of routine statistics and of a national household survey	53
Healthcare Workers’ (HCWs) attitudes towards mandatory influenza vaccination: A systematic review and meta-analysis	52
Willingness to get vaccinated against Covid-19 and attitudes toward vaccination in general	52
Willingness to pay and financing preferences for COVID-19 vaccination in China	52
A systematic review of communication interventions for countering vaccine misinformation	51
A global agenda for older adult immunization in the COVID-19 era: A roadmap for action	51
Incidence of community-acquired pneumonia in urban China: A national population-based study	51
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study	50
Influence of rapid COVID-19 vaccine development on vaccine hesitancy	50
Short term impact of the COVID-19 pandemic on incidence of vaccine preventable diseases and participation in routine infant vaccinations in the Netherlands in the period March-September 2020	50
Phase III: Randomized observer-blind trial to evaluate lot-to-lot consistency of a new plant-derived quadrivalent virus like particle influenza vaccine in adults 18–49 years of age	50
Immunoinformatics and molecular docking studies reveal a novel Multi-Epitope peptide vaccine against pneumonia infection	50
Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships	50
Global assessment of national mandatory vaccination policies and consequences of non-compliance	49
Misinformation and COVID-19 vaccine hesitancy	49
Vaccine acceptability, uptake and completion amongst men who have sex with men: A systematic review, meta-analysis and theoretical framework	49
Adapting the Motors of Influenza Vaccination Acceptance Scale into the Motors of COVID-19 Vaccination Acceptance Scale: Psychometric evaluation among mainland Chinese university students	48
Covid-19 vaccine immunogenicity in people living with HIV-1	48
Intranasal administration of a recombinant RBD vaccine induced protective immunity against SARS-CoV-2 in mouse	48
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice	48
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection	48
The impact of COVID-19 vaccines on fertility-A systematic review and meta-analysis	47
Impact of the COVID-19 pandemic on pediatric and adolescent vaccinations and well child visits in the United States: A database analysis	47
Childhood vaccinations: Hidden impact of COVID-19 on children in Singapore	47
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and olde	46
mRNA-1273 but not BNT162b2 induces antibodies against polyethylene glycol (PEG) contained in mRNA-based vaccine formulations	46
Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines	45
Parental vaccine hesitancy and its association with adolescent HPV vaccination	45
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults	45
Interpreting vaccine efficacy trial results for infection and transmission	45
A nationwide post-marketing survey of knowledge, attitude and practice toward human papillomavirus vaccine in general population: Implications for vaccine roll-out in mainland China	45
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group	44
Media usage predicts intention to be vaccinated against SARS-CoV-2 in the US and the UK	44
Disparities in national and state estimates of COVID-19 vaccination receipt and intent to vaccinate by race/ethnicity, income, and age group among adults ≥ 18 years, United States	44
Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study	44
Young age, female sex, and presence of systemic adverse reactions are associated with high post-vaccination antibody titer after two doses of BNT162b2 mRNA SARS-CoV-2 vaccination: An observational stu	43
Chlamydia trachomatis: Cell biology, immunology and vaccination	43
A phase 3, randomized, double-blind study to evaluate the immunogenicity and safety of 3 lots of 20-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naive adults 18 through 49 years of ag	43
Twitter discourse reveals geographical and temporal variation in concerns about COVID-19 vaccines in the United States	43
Vaccine effectiveness against infection and onwards transmission of COVID-19: Analysis of Belgian contact tracing data, January-June 2021	42
Underserved population acceptance of combination influenza-COVID-19 booster vaccines	42
Variable seasonal influenza vaccine effectiveness across geographical regions, age groups and levels of vaccine antigenic similarity with circulating virus strains: A systematic review and meta-analys	42
A trial to evaluate the safety and immunogenicity of a 20-valent pneumococcal conjugate vaccine in populations of adults ≥65 years of age with different prior pneumococcal vaccination	41
The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform	41
Henoch-Schönlein purpura presenting post COVID-19 vaccination	41
Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents	40
The missing season: The impacts of the COVID-19 pandemic on influenza	40
Joining the herd? U.S. public opinion and vaccination requirements across educational settings during the COVID-19 pandemic	40
Impact of the Sinopharm’s BBIBP-CorV vaccine in preventing hospital admissions and death in infected vaccinees: Results from a retrospective study in the emirate of Abu Dhabi, United Arab Emirates (UA	40
Child vaccination in sub-Saharan Africa: Increasing coverage addresses inequalities	40
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies	40
Differences and disparities in seasonal influenza vaccine, acceptance, adverse reactions, and coverage by age, sex, gender, and race	39
Safety of components and platforms of COVID-19 vaccines considered for use in pregnancy: A rapid review	39
COVID-19 vaccine uptake among healthcare workers in the fourth country to authorize BNT162b2 during the first month of rollout	39
The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies	39
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial	39
Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination	39
A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future	39
MTBVAC, a live TB vaccine poised to initiate efficacy trials 100 years after BCG	37
Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents	37
The development of COVID-19 vaccines in the United States: Why and how so fast?	37
Could live attenuated vaccines better control COVID-19?	37
COVID-19 vaccination significantly reduces morbidity and absenteeism among healthcare personnel: A prospective multicenter study	36
Individual factors influencing COVID-19 vaccine acceptance in between and during pandemic waves (July–December 2020)	36
Acceptance of a COVID-19 vaccine: A multifactorial consideration	36
Efficacy and safety of the BNT162b2 mRNA COVID-19 vaccine in participants with a history of cancer: subgroup analysis of a global phase 3 randomized clinical trial	36
Feasibility assessment of measles and rubella eradication	36
Myocarditis following COVID-19 vaccination – A case series	36
Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study	36
A validated modification of the vaccine hesitancy scale for childhood, influenza and HPV vaccines	36
Black-white disparities in 2009 H1N1 vaccination among adults in the United States: A cautionary tale for the COVID-19 pandemic	36

The sources and correlates of exposure to vaccine-related (mis)information online	35
The Novel Platform of mRNA COVID-19 Vaccines and Myocarditis: Clues into the Potential Underlying Mechanism	35
A nanogel-based trivalent PspA nasal vaccine protects macaques from intratracheal challenge with pneumococci	35
Safety of vaccines used for routine immunization in the United States: An updated systematic review and meta-analysis	35
Enabling accelerated vaccine roll-out for Public Health Emergencies of International Concern (PHEICs): Novel Oral Polio Vaccine type 2 (nOPV2) experience	35
Seropositivity to Nucleoprotein to detect mild and asymptomatic SARS-CoV-2 infections: A complementary tool to detect breakthrough infections after COVID-19 vaccination?	35
COVID-19 related immunization disruptions in Rajasthan, India: A retrospective observational study	35
Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020 - October 2021	35
COVID-19 vaccine hesitancy among persons living in homeless shelters in France	35
Continuity of routine immunization programs in Canada during the COVID-19 pandemic	34
Hypertension is associated with antibody response and breakthrough infection in health care workers following vaccination with inactivated SARS-CoV-2	34
Inactive SARS-CoV-2 vaccine generates high antibody responses in healthcare workers with and without prior infection	34
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies	34
Association of total and neutralizing SARS-CoV-2 spike -receptor binding domain antibodies with epidemiological and clinical characteristics after immunization with the 1st and 2nd doses of the BNT162	34
UAE efforts in promoting COVID-19 vaccination and building vaccine confidence	34
Disparities in COVID-19 vaccine uptake among health care workers	34
Looking ahead: Caregivers’ COVID-19 vaccination intention for children 5 years old and younger using the health belief model	34
India’s cost-effective COVID-19 vaccine development initiatives	34
Potential impact of COVID-19 pandemic on vaccination coverage in children: A case study of measles-containing vaccine administration in the United States (US)	33
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence	33
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials	33
Early exploration of COVID-19 vaccination safety and effectiveness during pregnancy: interim descriptive data from a prospective observational study	33
Anaphylactic reactions to novel mRNA SARS-CoV-2/COVID-19 vaccines	33
Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine	33
Non-clinical immunological comparison of a Next-Generation 24-valent pneumococcal conjugate vaccine (VAX-24) using site-specific carrier protein conjugation to the current standard of care (PCV13 and	33
Why do Hong Kong parents have low intention to vaccinate their children against COVID-19? testing health belief model and theory of planned behavior in a large-scale survey	32
Decreasing routine vaccination rates in children in the COVID-19 era	32
Predicting vaccine uptake during COVID-19 crisis: A motivational approach	32
Projecting the impact of a two-dose COVID-19 vaccination campaign in Ontario, Canada	32
Oral and laryngeal HPV infection: Incidence, prevalence and risk factors, with special regard to concurrent infection in head, neck and genitals	32
Immunogenicity and reactogenicity of BNT162b2 booster in BBIBP-CorV-vaccinated individuals compared with homologous BNT162b2 vaccination: Results of a pilot prospective cohort study from Lebanon	32
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years	32
Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study	32
Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo	32
Social amplification of risk and “probable vaccine damage”: A typology of vaccination beliefs in 28 European countries	32
The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barré syndrome	31
Understanding COVID-19 vaccine uptake during pregnancy: ‘Hesitance’, knowledge, and evidence-based decision-making	31
The changes in the epidemiology of hand, foot, and mouth disease after the introduction of the EV-A71 vaccine	31
Estimates of mortality associated with seasonal influenza for the European Union from the GLaMOR project	31
Parental attitudes towards mandatory vaccination; a systematic review	31
Acceptance, attitude, and factors affecting the intention to accept COVID-19 vaccine among Thai people and expatriates living in Thailand	31
COVID-19 vaccination coverage and intent among women aged 18–49 years by pregnancy status, United States, April–November 2021	31
Social media use and vaccine hesitancy in the European Union	31
Modern biotechnological strategies for vaccine development in aquaculture – Prospects and challenges	30
Influenza vaccination in the time of COVID-19: A national U.S. survey of adults	30
Imperfect messengers? An analysis of vaccine confidence among primary care physicians	30
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates	30
Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems	30
Kinetics of SARS-CoV-2 anti-S IgG after BNT162b2 vaccination	30
Understanding the messages and motivation of vaccine hesitant or refusing social media influencers	30
The effect of health literacy on COVID-19 vaccine hesitancy among community population in China: The moderating role of stress	29
Vaccination patterns of the northeast Ohio Amish revisited	29
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada	29
Sociodemographic and psychological correlates of COVID-19 vaccine hesitancy and resistance in the young adult population in Italy	29
“Any idea how fast ‘It’s just a mask!’ can turn into ‘It’s just a vaccine!’”: From mask mandates to vaccine mandates during the COVID-19 pandemic	29
Covax-19/Spikogen® vaccine based on recombinant spike protein extracellular domain with Advax-CpG55.2 adjuvant provides single dose protection against SARS-CoV-2 infection in hamsters	29
Dementia risk following influenza vaccination in a large veteran cohort	29
School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination	29
Effectiveness of adenovirus type 5 vectored and inactivated COVID-19 vaccines against symptomatic COVID-19, COVID-19 pneumonia, and severe COVID-19 caused by the B.1.617.2 (Delta) variant: Evidence fr	29
The role of manufacturers in the implementation of global traceability standards in the supply chain to combat vaccine counterfeiting and enhance safety monitoring	29
Patients with history of covid-19 had more side effects after the first dose of covid-19 vaccine	28
COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals	28
An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity	28
Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 – October 2021	28
Maintain and increase vaccination coverage in children, adolescents, adults and elderly people: Let's avoid adding epidemics to the pandemic	28
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines	28
COVID-19 vaccine uptake, effectiveness, and waning in 82,959 health care workers: A national prospective cohort study in Wales	28
Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries	28
Strategies to improve vaccination rates in people who are homeless: A systematic review	28
Misinformation about vaccine safety and uptake of COVID-19 vaccines among adults and 5–11-year-olds in the United States	27
The humoral immune response to high-dose influenza vaccine in persons with monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)	27
Recent MMR vaccination in health care workers and Covid-19: A test negative case-control study	27
COVID-19 vaccination intention and behavior in a large, diverse, U.S. refugee population	27
Is vaccine confidence an unexpected victim of the COVID-19 pandemic?	27
Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2)	27
Thrombosis with Thrombocytopenia Syndrome (TTS) following AstraZeneca ChAdOx1 nCoV-19 (AZD1222) COVID-19 vaccination – A risk–benefit analysis for people < 60 years in Australia	27
A novel gonorrhea vaccine composed of MetQ lipoprotein formulated with CpG shortens experimental murine infection	27
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021	27
Immunogenicity and safety of a nine-valent human papillomavirus vaccine in women 27–45 years of age compared to women 16–26 years of age: An open-label phase 3 study	27
Prevalence of pain and fear as barriers to vaccination in children – Systematic review and meta-analysis	27
Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials	27
NIH funding for vaccine readiness before the COVID-19 pandemic	27
Guidance for design and analysis of observational studies of fetal and newborn outcomes following COVID-19 vaccination during pregnancy	27
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants	26
The efficacy and safety of rotavirus vaccines in countries in Africa and Asia with high child mortality	26
The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion	26
A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects	26
SARS-CoV-2 vaccine for domestic and captive animals: An effort to counter COVID-19 pandemic at the human-animal interface	26
Rural, urban, and suburban differences in influenza vaccination coverage among children	26
A systematic review of factors that influence the acceptability of vaccines among Canadians	26
Immune thrombocytopenia following immunisation with Vaxzevria ChadOx1-S (AstraZeneca) vaccine, Victoria, Australia	26
Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine	26
A self-administered virtual reality intervention increases COVID-19 vaccination intention	26
Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452	26
Vaccine effectiveness against transmission of alpha, delta and omicron SARS-COV-2-infection, Belgian contact tracing, 2021–2022	26